Characterisation of large and small subunit rRNA and mini-exon genes further supports the distinction of six Trypanosoma cruzi lineages
Introduction
Trypanosoma (Schizotrypanum) cruzi is the aetiological agent of Chagas disease, which remains a major health problem in Central and South America, with an estimated 16–18 million infected (World Health Organization, 1991). Trypanosoma cruzi is widespread in wild mammals and vectors from the USA to the southern cone countries of South America. In humans, Chagas disease is characterised by a wide spectrum of clinical outcomes, ranging in severity from asymptomatic infections to severe cardiac and digestive tract damage.
Understanding the complex epidemiology and variety of pathogenic behaviours of T. cruzi requires a clear picture of the parasite's genetic diversity and easy strain characterisation schemes. The tremendous genetic diversity of T. cruzi populations was recognised long ago, based mostly on multilocus enzyme electrophoresis (MLEE; Miles et al., 1978, Tibayrenc et al., 1986), and their predominantly clonal population structure was demonstrated (Tibayrenc et al., 1986, Tibayrenc and Ayala, 1988). Successive uncoordinated proposals to describe T. cruzi genetic variants have resulted in a confusing profusion of independent descriptions (Momen, 1999). In recent years, a dominant focus has been put on the subdivision of T. cruzi into two primary phylogenetic lineages (Tibayrenc, 1995), initially based on MLEE and random amplified polymorphic DNA (RAPD) data (Tibayrenc et al., 1993). A similar conclusion was drawn after analysis of the 24Sα rRNA genes and the non-transcribed spacer of the mini-exon genes (Souto et al., 1996), of the promoter regions of the rRNA and mini-exon genes (Nunes et al., 1997), and of the 195 bp DNA repeat (Bastrenta et al., 1999). This apparent convergence lead to efforts to harmonise T. cruzi lineages denomination (Anonymous, 1999). However, the exact correspondence between the MLEE/RAPD lineages (Tibayrenc, 1995) and the rRNA/mini-exon lineages (Souto et al., 1996) has never been carefully checked by parallel analysis of a representative set of strains. In particular, it is important to realise that MLEE/RAPD lineage 2 was defined in a broader way than the corresponding rRNA/mini-exon lineage (Table 1). Moreover, recent MLEE and RAPD analysis of a larger set of T. cruzi isolates demonstrated the distinction of five lower phylogenetic subdivisions, designated IIa–IIe, within the MLEE/RAPD lineage 2, whereas no clear subdivision was found within the first lineage (Barnabé et al., 2000, Brisse et al., 2000a). Thus, six phylogenetic subdivisions can be distinguished within T. cruzi, but the correspondence between this refined MLEE/RAPD classification scheme and the two major rRNA/mini-exon lineages is unknown, rendering it very difficult to interpret epidemiological or evolutionary studies based on the widely used rRNA/mini-exon characterisation. In order to investigate this correspondence and help further harmonisation of T. cruzi infra-specific nomenclature, and to determine whether the six lineages can also be demarcated by these markers, we analysed representative strains of each of the six RAPD/MLEE lineages using the 24Sα rRNA and mini-exon PCR markers (Souto et al., 1996). In addition, we investigated the relevance of the size polymorphism of the 18S rRNA genes (Clark and Pung, 1994) for lineage identification.
Section snippets
Trypanosome stocks and sample preparation
A total of 44 T. cruzi stocks, equally distributed into the six MLEE/RAPD groups, were investigated (Table 2). In addition, two T. cruzi-like stocks, two Trypanosoma cruzi marinkellei bat trypanosome stocks and two Trypanosoma rangeli stocks were included for comparison (Table 2). The detailed origin of the stocks is given in Brisse et al. (2000a). The MLEE/RAPD lineage to which the stocks belong had been determined either by MLEE at 22 isoenzyme loci (Barnabé et al., 2000), by RAPD using 20
Analysis of the D7 domain of the 24Sα rRNA
The PCR amplification products obtained after characterisation of the 24Sα rRNA of the 50 trypanosome stocks are given in Table 2. Most generally, only one PCR product was observed. In some stocks of lineage IId, a second, weakly amplified product of 125 bp was observed (lane 1 of Fig. 1; Table 2), but it was not taken into account in the analysis because it was either difficult to observe or not visible, depending on the sample. Five PCR products of distinct sizes were found, as determined by
Variability of the three PCR markers within Trypanosoma cruzi
Fourteen reference strains, representative of lineages I, IIb, IIc, IId and IIe, were common to our study and that of Souto et al. (1996) (Table 2). The results obtained for these strains are identical between our study and that of Souto et al. (1996), with the only exception of the stock IIa-CanIII cl1 (rRNA: 125 bp; ME: 300 bp in Souto et al. (1996)) which is likely to be due to strain mix-up (Fernandes et al., 1998b).
The 24Sα rRNA variation found across our T. cruzi sample was higher than
References (36)
- et al.
Molecular epidemiology and evolutionary genetics of Leishmania parasites
Int. J. Parasitol.
(1999) - et al.
Different behavior of two Trypanosoma cruzi major clones: transmission and circulation in young Bolivian patients
Exp. Parasitol.
(1998) - et al.
The evolution of two Trypanosoma cruzi subgroups inferred from rRNA genes can be correlated with the interchange of American mammalian faunas in the Cenozoic and has implications to pathogenicity and host specificity
Mol. Biochem. Parasitol.
(1999) - et al.
Identification of six Trypanosoma cruzi phylogenetic lineages by random amplified polymorphic DNA and multilocus enzyme electrophoresis
Int. J. Parasitol.
(2000) - et al.
Identification of six Trypanosoma cruzi lineages by sequence-characterised amplified region markers
Mol. Biochem. Parasitol.
(2000) - et al.
Trypanosoma cruzi: compared vectorial transmissibility of three major clonal genotypes by Triatoma infestans
Exp. Parasitol.
(1998) - et al.
The mini-exon gene: a genetic marker for zymodeme III of Trypanosoma cruzi
Mol. Biochem. Parasitol.
(1998) The epidemiology of South American trypanosomiasis — biochemical and immunological approaches and their relevance to control
Trans. R. Soc. Trop. Med. Hyg.
(1983)- et al.
Chagas's disease in the Amazon Basin: II. The distribution of Trypanosoma cruzi zymodemes 1 and 3 in Para State, North Brazil
Trans. R. Soc. Trop. Med. Hyg.
(1981) - et al.
Trypanosoma cruzi strains partition into two groups based on the structure and function of the spliced leader RNA and rRNA gene promoters
Mol. Biochem. Parasitol.
(1997)